Muscle Cell News 4.04 February 4, 2019 | |
| |
TOP STORYThrough a small-molecule screen, researchers identified epidermal growth factor receptor and aurora kinase A as regulators of asymmetric satellite cell divisions. [Cell Stem Cell] Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)CARDIAC MUSCLE CELLSSarcTrack analysis of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) carrying a heterozygous truncation variant in the myosin-binding protein C gene, which caused hypertrophic cardiomyopathy, recapitulated seminal disease phenotypes including cardiac hypercontractility and diminished relaxation, abnormalities that normalized with myosin molecule treatment. [Circ Res] Abstract Scientists report comprehensive gene expression profiles of human cardiac derivatives from multipotent cardiac stem/progenitor cells to intermediates and mature cardiac cells by population and single-cell RNA-seq using human embryonic stem cell-derived and embryonic/fetal heart-derived cardiac cells micro-dissected from specific heart compartments. [Dev Cell] Full Article | Graphical Abstract The effects of seeding density and a change in hippo/Yes-associated protein signaling on 3D cardiovascular spheroids patterning from human pluripotent stem cells were evaluated. Compared to 2D culture, 3D cardiovascular spheroids exhibited higher levels of sarcomeric striations and higher length-to-width ratios of α-actinin+ cells. [Sci Rep] Full Article SKELETAL MUSCLE CELLSBiohybrid Valveless Pump-Bot Powered by Engineered Skeletal Muscle The authors developed an example of a biohybrid valveless pump-bot powered by engineered skeletal muscle. The pump-bot consisted of a soft hydrogel tube connected at both ends to a stiffer polydimethylsiloxane scaffold, creating an impedance mismatch. A contractile muscle ring wrapped around the hydrogel tube at an off-center location, squeezing the tube with or without buckling it locally. [Proc Natl Acad Sci USA] Full Article Researchers investigated whether there was a direct effect of increased glucose uptake by skeletal muscle. Incubation of primary human skeletal muscle cells -with apoA-I increased insulin-dependent and insulin–independent glucose uptake in a time- and concentration-dependent manner. [Sci Rep] Full Article SMOOTH MUSCLE CELLSAirway Smooth Muscle-Specific Transcriptomic Signatures of Glucocorticoid Exposure Scientists sought to identify differences between fatal asthma and non-asthma donor-derived airway smooth muscle (ASM) cell transcriptomic response to glucocorticoid exposure, and to compare ASM-specific changes to those of other cell types. [Am J Respir Cell Mol Biol] Abstract The authors demonstrated that the Warburg effect played a pivotal role in apelin-13-induced human aortic vascular smooth muscle cell proliferation. Apelin-13 promoted the expression of glucose transporter type 1, pyruvate kinase 2, lactate dehydrogenase A, monocarboxylate transporter 1, and monocarboxylate transporter 4 in a dose- and time-dependent manner. [J Cell Physiol] Abstract Investigators demonstrated the absence of spatial regulation in dedifferentiated smooth muscle cells using both cell lines and primary cells, thus distinct from previous reports on cells with migratory potential. They also observed that the spatial regulation was partly induced upon fibronectin stimulation and Klf4 overexpression. [Am J Physiol Cell Physiol] Abstract Subscribe to one of our other 19 science newsletters such as Extracellular Matrix News & ESC & iPSC News. | |
| |
REVIEWSCardiac Repair and the Putative Role of Stem Cells The efficacy of stem cell therapy to produce sustained beneficial effects in patients with ischemic and non-ischemic heart disease remains unproven. It is an open question as to whether new scientific discovery can provide a convincing rationale for further clinical trials of cardiac stem cell therapy. [J Mol Cell Cardiol] Abstract Visit our reviews page to see a complete list of reviews in the muscle cell research field. | |
| |
INDUSTRY NEWSVerseon Reports First Dosing in Phase I Trial on New Precision Oral Anticoagulant Verseon announces that dosing has started in the Phase I clinical trial of VE-1902, the company’s leading candidate for a new class of precision oral anticoagulants (PROACs). Preclinical data suggest that PROACs could become the first anticoagulants suitable for long-term co-administration with antiplatelet agents for the prevention of stroke and heart attack in coronary artery disease patients [Verseon Corporation] Press Release Lupin is pleased to announce that NaMuscla® has been launched in Germany and the United Kingdom. NaMuscla® is approved across the European Union for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic disorders. [LUPIN (GlobeNewswire, Inc)] Press Release | |
| |
POLICY NEWSIndian Government to Boost Stipend for Early-Career Scientists The Indian government announced that it will increase the stipend for PhD students who have qualified for a research fellowship by up to 25%. [Nature News] Editorial After Shutdown, NSF Catching Up on Review Panels, Funding Requests When the US government was partially shut down for 35 days starting December 22, work at several government agencies ground to a halt, with a total of 800,000 federal employees furloughed. The National Science Foundation (NSF), one of the sidelined science agencies, is now addressing all that went undone during that time, NSF officials told reporters. [The Scientist] Editorial
| |
EVENTSNEW Gordon Research Conference: Chromatin Signaling in Heart and Vascular Diseases Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Fellow – Stem cells & Cardiac Regeneration (Temple University) NEW Assistant Specialist – Cardiovascular Research (University of California, Davis) NEW Postdoctoral Research Associate – Cardiac Stem Cells (University of Louisville) Postdoctoral Research Position – Cardiovascular Medicine (University of California, Davis) Assistant Professor – Sarcoma & Skeletal-Related Malignancies (UC Davis School of Medicine) Scientist – Myotonic Dystrophy Type 1 Drug Discovery (Expansion Therapeutics, Inc.) Postdoctoral Fellowship – Cardiovascular Sciences (Medical College of Wisconsin) Assistant/Associate Adjunct Professor – Cardiovascular Medicine (University of California Davis) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Muscle Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|